Vicarious Surgical (RBOT) Long-Term Deferred Tax (2020 - 2021)
Vicarious Surgical's (RBOT) quarterly Long-Term Deferred Tax came in at $22.8 million in Q4 2021, up 199.58% year-on-year from $7.6 million in Q4 2020, and up 199.58% on a QoQ basis from $7.6 million in Q4 2020.
Vicarious Surgical (RBOT) Long-Term Deferred Tax (2020 - 2021) Analysis & Trends
Vicarious Surgical (RBOT) has 2 years of Long-Term Deferred Tax data on file, last reported at $22.8 million in Q4 2021.
- On a quarterly basis, Long-Term Deferred Tax rose 199.58% year-over-year to $22.8 million in Q4 2021; TTM through Dec 2021 was $22.8 million, a 199.58% increase from a year earlier, with the FY2021 full-year figure at $22.8 million, up 199.58% from the prior year.
- Long-Term Deferred Tax for Q4 2021 stood at $22.8 million, up from $7.6 million in the prior quarter.
- Over the last five years, Long-Term Deferred Tax for RBOT reached as high as $22.8 million in Q4 2021 and fell as low as $7.6 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Vicarious Surgical | 654,984.55 | -9.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 22.77 Mn |
| Dec 31, 2020 | 7.60 Mn |